A1cNow Exam Room A1c Test

Login to your account:

Don't have an account? Create one now! 

Questions? Call us toll-free at 1-888-345-4858

A1cNow Exam Room A1c Test

A1cNow InView - Multi-Test System
84% of Type 2's think they're doing fine1.
But in reality, 67% of those patients are out of control - if they feel nothing's wrong, they see no need to do anything differently.
But the immediate results from an in-office A1C test can help open their eyes.
A1cNow InView

Uses micro-optical technology that provides results equivalent to the most sophisticated lab equipment
With immediate results, physicians are twice as likely to modify treatment right on the spot 2.
Immediate, face-to-face counseling about your patients' A1C results may motivate patients to actually do the things you tell them to do.

• Patients who get immediate feedback may lower their A1C by up to 1%3,4 Lowering A1C levels reduces the risks of long term complications.

• It's been shown that a 1% reduction in A1C lowers risk of complications such as eye, kidney and nerve disease by 40% 5.

A1cNow® InView encourages immediate face-to-face counseling.
It lets you test right in the exam room.
A1cNow InView encourages immediate face-to-face counselingResults in just 5 minutes.
Actual hands on time: less than 1 minute.6
No waiting for lab results.

It's CLIA-Waived.
It's lab-accurate at 99%.
It's easy to use.
No calibration.
No daily controls.

A1cNow InView is reimbursable. 7
Billable to CPT Code 83036QW.
Medicare coverage is $13.56.
Private insurance national average pays $18.00.8

Immediate Results Impacts Treatment Modification2
First Visit With Immediate
Feedback		 With Delayed
Feedback (Lab)
52% 27%

Advanced Technology
Uses micro-optical technology that provides results equivalent to the most sophisticated lab equipment.
Simultaneously conducts two, independent A1C tests and compares the results to ensure accuracy.
Utilizes both immunoassay and chemistry technology.
<
NGSP Certified
Satisfaction Guaranteed
Collect sample via fingerstick or venipuncture. Place sample in A1cNow InView dilution solution and mix. Insert cartridge and add diluted sample to the monitor.
Collect sample via fingerstick or venipuncture. Place sample in A1cNow InView dilution solution and mix. Insert cartridge and add diluted sample to the monitor.
Collect sample via fingerstick or venipuncture. Place sample in A1cNow InView dilution solution and mix. Insert cartridge and add diluted sample to the monitor.
06708306-3024 A1cNow InView- Ten Pack
Return Policy For Professional Use
QuickMedical Price: $120.00
In Stock
Add this Medical Supply/Equipment

Shipping Information

More Information - PDF Download		 The A1cNow® InView test provides quantitative measurement of the percent of glycated hemoglobin (%A1C) levels in capillary (fingerstick) or venous whole blood samples. The test is for professional use to monitor glycemic control in people with diabetes.

Calibration of the A1cNow InView is performed with a set of blood samples that have been value-assigned by a National Glycohemoglobin Standardization Program (NGSP) certified laboratory using an NGSP reference method. Total Hb calibration values for those samples are obtained with a Total Hb analyzer (HemoCue B-Hemoglobin System, HemoCue Ab, Ångelholm, Sweden). The calibration of the A1cNow InView test is thus traceable to the NGSP and to an NGSP Certified Network reference method.


1 State of Diabetes in America, A Comprehensive Report Issued by the American Association of Clinical Endocrinologists, 2005 - Data on file. 2 Ferenczi A et al., Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract 2001; 7:85-88. 3 Miller CD et al., Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26:1158- 1163. 4 Cagliero E et al., Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999; 22: 1785-1789. 5 Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2002. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2003. 6 Data on file. 7 Reimbursement rates may vary based upon geographical location, third party payer changes and other factors, and are subject to change in the future. 8 Metrika estimate.